Financial Performance - Net sales for Q2 2024 were $599.4 million, a 0.2% increase year-over-year, with organic net sales up 0.1%[3] - GAAP EPS rose to $0.72, a 95% increase from $0.37 in the prior year quarter, while adjusted EPS increased to $0.88, up 57% from $0.56[3] - Gross profit was $258.1 million, with a gross margin of 43.1%, reflecting a 260-basis point increase compared to the prior year[5] - Adjusted EBITDA for Q2 2024 was $99.7 million, compared to $83.6 million in the prior year quarter[12] - Operating income increased to $70.1 million for the three months ended March 31, 2024, up from $56.8 million in the prior year, marking a growth of 23.1%[33] - Net earnings for the six months ended March 31, 2024, were $40.8 million, compared to $31.8 million in the same period of 2023, indicating a year-over-year increase of 28.3%[33] - Free cash flow for the six months ended March 31, 2024, was $56.1 million, significantly higher than $1.9 million in the same period of 2023[38] - GAAP reported net earnings for Q2 2024 were $36.0 million, with diluted EPS of $0.72, compared to $19.4 million and $0.37 in Q2 2023, representing a 85.0% increase in net earnings and a 94.6% increase in EPS[43] - Total adjusted non-GAAP net earnings for Q2 2024 were $44.0 million, with diluted EPS of $0.88, compared to $29.4 million and $0.56 in Q2 2023, reflecting a 49.5% increase in net earnings and a 57.1% increase in EPS[43] Segment Performance - The Wet Shave segment reported net sales of $293.1 million for the three months ended March 31, 2024, down from $308.6 million in 2023, a decline of 5.5%[41] - The Sun and Skin Care segment saw an increase in net sales to $235.8 million for the three months ended March 31, 2024, compared to $209.7 million in the same period of 2023, a growth of 12.4%[41] - The Wet Shave segment reported Q2 2024 net sales of $293.1 million, down 5.0% from $308.6 million in Q2 2023, while the Sun and Skin Care segment saw an increase of 12.4% to $235.8 million[50] - The Feminine Care segment experienced a decline in Q2 2024 net sales to $70.5 million, down 12.0% from $80.1 million in Q2 2023[50] - Total segment profit for the three months ended March 31, 2024, was $103.5 million, up from $87.6 million in the same period of 2023, reflecting a growth of 18.2%[41] - Segment profit for Q2 2024 reached $103.5 million, an increase of 18.2% compared to Q2 2023's $87.6 million[52] - Organic growth in the Wet Shave segment was 19.2%, with segment profit increasing from $35.4 million in Q2 2023 to $40.4 million in Q2 2024[52] - The Sun and Skin Care segment saw a profit decrease of 28.7%, with segment profit at $8.7 million in Q2 2024 compared to $12.2 million in Q2 2023[52] Shareholder Returns and Dividends - The company returned $23.5 million to shareholders through share repurchases of $15.3 million and dividends of $8.2 million[3] - The Board declared a cash dividend of $0.15 per common share for Q2 2024, payable on July 9, 2024[15] Future Outlook - Organic net sales growth is now expected to be at the lower end of the 2% to 4% range for the full fiscal year 2024[20] - Adjusted EPS outlook for fiscal 2024 has been raised to a range of $2.80 to $3.00, previously $2.65 to $2.85[20] - The company expects adjusted EBITDA for fiscal 2024 to be in the range of $348 to $360 million, up from the previous range of $340 to $352 million[20] - Capital expenditures are expected to be approximately 2.5% to 3.0% of net sales for fiscal 2024[20] - The company expects fiscal 2024 GAAP EPS to be in the range of $2.20 to $2.40, with adjusted EPS projected at approximately $2.80 to $3.00[56] - Interest expense for the fiscal year is estimated at approximately $75 million, indicating a stable financial outlook[57] Financial Position - The company’s total assets increased to $3,756.3 million as of March 31, 2024, compared to $3,740.7 million as of September 30, 2023[36] - Net debt as of March 31, 2024, was $1,178.2 million, slightly up from $1,163.8 million as of September 30, 2023[55] - The net debt leverage ratio is defined as net debt divided by trailing twelve-month adjusted EBITDA, providing insight into the company's financial leverage[31] Restructuring and Expenses - The company incurred restructuring and repositioning expenses of $10.0 million for the six months ended March 31, 2024, impacting overall profitability[45] - The company incurred restructuring and repositioning expenses of approximately $19 million for fiscal 2024, which will affect adjusted earnings[57] Currency Impact - The impact of currency fluctuations on segment profit was minimal, with a total impact of $(0.7) million for Q2 2024[52]
Edgewell Personal Care(EPC) - 2024 Q2 - Quarterly Results